1 year return (CAGR)
-61.69%
Ocuphire Pharma Inc Exchange (NASDAQ, USD)
OCUP
-
-0.04 (-3.42%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-36.00%
5 year return (CAGR)
-31.84%
10 year return (CAGR)
-43.50%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
29.60M
Price/Sales
1.80
Ent value
-7.61M
Price/Book
0.73
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 1.19 |
| Daily high | 1.20 |
| Daily low | 1.10 |
| Daily Volume | 177K |
| 1y analyst estimate | 13.67 |
| Beta | 0.31 |
| EPS (TTM) | -0.55 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| OCUP | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.92% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 24 Oct 2024 | 9 Mar 2009 |
| Avg drop from high | -99.74% | -10.68% |
| Avg time to new high | 2249 days | 12 days |
| Max time to new high | 4495 days | 1805 days |
News
No items found